SCHEMBL4473176

SCHEMBL4473176

Cc1cc(O)c(Cc2ccccc2)c(=O)n1Cc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.54
MEN1 O00255 4/20 0.54
POLB P06746 3/20 0.54
ALDH1A1 P00352 5/20 0.49
LMNA P02545 3/20 0.49
HTT P42858 1/20 0.49
NOTUM Q6P988 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
MAPK1 P28482 1/20 0.48
SRC P12931 1/20 0.47
IDH1 O75874 1/20 0.46
KDM4E B2RXH2 4/20 0.45
HPGD P15428 3/20 0.45
HSD17B10 Q99714 1/20 0.45
MAPT P10636 2/20 0.45
PPARG P37231 1/20 0.44
NCOA2 Q15596 1/20 0.44
NCOA1 Q15788 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12081323 0.83 PPARG (0.45) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL13678555 0.83 NOTUM (0.53) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL13678559 0.81 ALDH1A1 (0.50) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL4382351 0.81 ALDH1A1 (0.50) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL2279827 0.78 SMN1; SMN2 (0.59) KMT2AMEN1ALDH1A1LMNAHTT
SCHEMBL3524860 0.77 CYP2C9 (0.50) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL31560450 0.76 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1LMNANOTUM
SCHEMBL6587073 0.75 KDM4E (0.55) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL28480430 0.74 LMNA (0.50) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL17917621 0.73 HPGD (0.53) KMT2AMEN1POLBALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058964-A1 Substituted pyridinones PHARMACIA LLC 2004-03-25 US claimed
US-7629363-B2 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease PFIZER INC (US) 2009-12-08 US disclosed
US-7067540-B2 Substituted pyridinones PHARMACIA CORPORATION (US) 2006-06-27 US disclosed
US-20050176775-A1 Substituted pyridinones PHARMACIA CORPORATION 2005-08-11 US disclosed
US-20040058964-A1 Substituted pyridinones PHARMACIA LLC 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058964-A1 Substituted pyridinones MAPK1, MAPK6, MAPK7 KMT2A 4674/4885MEN1 4261/4885POLB 1610/4885
US-20050176775-A1 Substituted pyridinones MAPK1, MAPK6, MAP3K6 KMT2A 4574/4885MEN1 3919/4885POLB 1676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.